University Hospital Zurich, Switzerland.
J Am Coll Cardiol. 2011 Jan 18;57(3):332-6. doi: 10.1016/j.jacc.2010.08.634.
We sought to assess the feasibility of prospective electrocardiogram triggering for achieving low-dose computed tomography coronary angiography (CTCA) in a large population.
Prospective electrocardiogram triggering dramatically reduces radiation exposure for CTCA but requires heart rate (HR) control to obtain diagnostic image quality. Its feasibility in daily clinical routine has therefore remained to be elucidated.
We evaluated 612 patients consecutively referred for CTCA by 64-slice computed tomography. Intravenous metoprolol (2 to 30 mg) was administered if necessary to achieve a target HR below 65 beats/min. Image quality was assessed on a semiquantitative 4-point scale for each coronary segment.
Forty-six (7.5%) patients were deemed ineligible due to irregular heart rhythm (n = 19), insufficient response to metoprolol (n = 21), renal insufficiency (n = 3), or inability to follow breath-hold commands (n = 3). Mean effective radiation dose was 1.8 ± 0.6 mSv with a diagnostic image quality in 96.2% of segments. Finally, low-dose CTCA allowed a firm diagnosis with regard to the presence or absence of coronary artery disease in 527 (86.1%) patients. Intravenous metoprolol to achieve an HR below 65 beats/min was used in 64.4% of patients. Incidence of nondiagnostic segments was inversely related to HR (r = -0.809, p < 0.001). Below an HR cutoff of 62 beats/min, only 1.2% of coronary segments were nondiagnostic.
Low-dose CTCA by electrocardiogram triggering is feasible in the vast majority of an every-day population. However, HR control is crucial, as an HR below 62 beats/min favors diagnostic image quality.
我们旨在评估前瞻性心电图触发在大人群中实现低剂量 CT 冠状动脉成像(CTCA)的可行性。
前瞻性心电图触发可显著降低 CTCA 的辐射暴露,但需要控制心率(HR)以获得诊断图像质量。因此,其在日常临床实践中的可行性仍有待阐明。
我们评估了 612 例连续因 64 层 CT 而转诊行 CTCA 的患者。如果需要,静脉注射美托洛尔(2 至 30mg)以将目标 HR 控制在 65 次/分以下。对每个冠状动脉节段进行半定量 4 分制的图像质量评估。
由于心律不齐(n = 19)、美托洛尔反应不足(n = 21)、肾功能不全(n = 3)或无法遵循屏气指令(n = 3),46 例(7.5%)患者被认为不符合条件。平均有效辐射剂量为 1.8 ± 0.6mSv,96.2%的节段获得诊断图像质量。最终,低剂量 CTCA 允许在 527 例(86.1%)患者中对冠状动脉疾病的存在或不存在做出明确诊断。64.4%的患者使用静脉注射美托洛尔将 HR 控制在 65 次/分以下。非诊断节段的发生率与 HR 呈反比(r = -0.809,p <0.001)。HR 低于 62 次/分时,只有 1.2%的冠状动脉节段无法诊断。
在绝大多数日常人群中,通过心电图触发进行低剂量 CTCA 是可行的。然而,HR 控制至关重要,因为 HR 低于 62 次/分有利于获得诊断图像质量。